These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1398623)
1. [Study on variation of plasma gamma-aminobutyric acid concentration in rat model of hepatic encephalopathy due to fulminant hepatic failure]. He X; Luan Y Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):45-8. PubMed ID: 1398623 [TBL] [Abstract][Full Text] [Related]
2. Plasma gamma-aminobutyric acid in experimental fulminant hepatic failure of rats and its diagnostic value in hepatic encephalopathy. Wang F; Niu Z; Li ZM Chin Med J (Engl); 1990 Mar; 103(3):197-200. PubMed ID: 2114962 [TBL] [Abstract][Full Text] [Related]
3. Metabolism and brain uptake of gamma-aminobutyric acid in galactosamine-induced hepatic encephalopathy in rats. Zeneroli ML; Iuliano E; Racagni G; Baraldi M J Neurochem; 1982 May; 38(5):1219-22. PubMed ID: 7062047 [TBL] [Abstract][Full Text] [Related]
4. Brain gamma-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma gamma-aminobutyric acid-like activity. Maddison JE; Dodd PR; Johnston GA; Farrell GC Gastroenterology; 1987 Nov; 93(5):1062-8. PubMed ID: 2820827 [TBL] [Abstract][Full Text] [Related]
5. Serum gamma-aminobutyric acid (GABA) levels in patients with hepatic encephalopathy. Minuk GY; Winder A; Burgess ED; Sarjeant EJ Hepatogastroenterology; 1985 Aug; 32(4):171-4. PubMed ID: 4054811 [TBL] [Abstract][Full Text] [Related]
6. Reduction of highly elevated plasma levels of gamma-aminobutyric acid does not reverse hepatic coma. Löscher W; Kretz FJ; Tung LC; Dillinger U Hepatogastroenterology; 1989 Dec; 36(6):504-5. PubMed ID: 2613172 [TBL] [Abstract][Full Text] [Related]
7. [Association of plasma ammonia and GABA levels and the degree of hepatic encephalopathy]. Campollo O; MacGillivray BB; McIntyre N Rev Invest Clin; 1992; 44(4):483-90. PubMed ID: 1485027 [TBL] [Abstract][Full Text] [Related]
8. Evidence for gamma-aminobutyric acid as the inhibitor of gamma-aminobutyric acid binding in the plasma of humans with liver disease and hepatic encephalopathy. Levy LJ; Leek J; Losowsky MS Clin Sci (Lond); 1987 Nov; 73(5):531-4. PubMed ID: 3677559 [TBL] [Abstract][Full Text] [Related]
9. Plasma GABA-like activity in rats with hepatic encephalopathy is due to GABA and taurine. Maddison JE; Leong DK; Dodd PR; Johnston GA Hepatology; 1990 Jan; 11(1):105-10. PubMed ID: 1967242 [TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy. No evidence for increased GABA-transport. Knudsen GM; Poulsen HE; Paulson OB J Hepatol; 1988 Apr; 6(2):187-92. PubMed ID: 3411098 [TBL] [Abstract][Full Text] [Related]
11. Increased brain uptake of gamma-aminobutyric acid in a rabbit model of hepatic encephalopathy. Bassett ML; Mullen KD; Scholz B; Fenstermacher JD; Jones EA Gastroenterology; 1990 Mar; 98(3):747-57. PubMed ID: 2298374 [TBL] [Abstract][Full Text] [Related]
12. Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins. Pappas SC; Ferenci P; Schafer DF; Jones EA Gastroenterology; 1984 Mar; 86(3):546-51. PubMed ID: 6693016 [TBL] [Abstract][Full Text] [Related]
13. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Zimmermann C; Ferenci P; Pifl C; Yurdaydin C; Ebner J; Lassmann H; Roth E; Hörtnagl H Hepatology; 1989 Apr; 9(4):594-601. PubMed ID: 2564368 [TBL] [Abstract][Full Text] [Related]
14. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease. Levy LJ; Losowsky MS Hepatogastroenterology; 1989 Dec; 36(6):494-8. PubMed ID: 2613171 [TBL] [Abstract][Full Text] [Related]
15. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. Schafer DF; Fowler JM; Munson PJ; Thakur AK; Waggoner JG; Jones EA J Lab Clin Med; 1983 Dec; 102(6):870-80. PubMed ID: 6315836 [TBL] [Abstract][Full Text] [Related]
16. Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid. Moroni F; Riggio O; Carlà V; Festuccia V; Ghinelli F; Marino IR; Merli M; Natali L; Pedretti G; Fiaccadori F Hepatology; 1987; 7(5):816-20. PubMed ID: 3653849 [TBL] [Abstract][Full Text] [Related]
17. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Baraldi M; Zeneroli ML; Ventura E; Penne A; Pinelli G; Ricci P; Santi M Clin Sci (Lond); 1984 Aug; 67(2):167-75. PubMed ID: 6086210 [TBL] [Abstract][Full Text] [Related]
18. Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems. Dixit V; Chang TM ASAIO Trans; 1990; 36(1):21-7. PubMed ID: 2306387 [TBL] [Abstract][Full Text] [Related]
19. Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model. Dixit V; Chang TM Biomater Artif Cells Artif Organs; 1987; 15(3):559-73. PubMed ID: 3481555 [TBL] [Abstract][Full Text] [Related]
20. [The blood level of gamma-aminobutyric acid in patients with liver cirrhosis and portacaval anastomosis]. Kretz FJ; Löscher W; Dillinger U Anaesthesiol Reanim; 1991; 16(3):169-74. PubMed ID: 1888423 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]